Numerous studies now show that epigallocatechin gallate (EGCG), a substance found in green tea, can help fight various types of coronaviruses, including variants of SARS-CoV-2, the virus responsible for COVID-19. Notably, therefore, EGCG has long been a key component of the cutting-edge micronutrient program designed by scientists at the Dr. Rath Research Institute.
Green tea polyphenols have potent antioxidant and anti-inflammatory properties which contribute to their anticancer effects, cardiovascular benefits, and support of overall health. In addition to COVID-19, other conditions for which green tea and its extracts may be helpful include rheumatoid arthritis, Parkinson’s disease, and Alzheimer’s disease.
Recent research conducted at the Dr. Rath Research Institute has revealed amazing benefits of black tea that could prove to be game-changing in the battle against bacterial infections. These findings are especially significant given the growing threat of antibiotic resistance, a problem that limits the options for fighting difficult-to-treat infections such as methicillin-resistant Staphylococcus aureus (MRSA). Published in the prestigious journal PLOS ONE, the research utilizes a specific component of black tea known as theaflavin 3,3′-digallate (TF3).
To read how the United States Patent and Trademark Office has awarded the Dr. Rath Research Institute a patent on a game-changing micronutrient formula that can simultaneously inhibit multiple cellular mechanisms of infectivity caused by coronavirus, its variants, and mutants, see this article on our website.
Secret COVID-19 Vaccine Exemptions for Healthcare Workers in New Zealand
October 12, 2023CIA Bribed Its Own COVID-19 Origin Team To Reject Lab-Leak Theory, Anonymous Whistleblower Claims
October 12, 2023Green, Matcha, And Black Tea: Effective Weapons Against Omicron Subvariants, Research Reveals
News
A recent study published in the journal Scientific Reports has demonstrated that green tea, Matcha, and black tea effectively inactivate Omicron subvariants.
[Source: news-medical.net]
Comment
Numerous studies now show that epigallocatechin gallate (EGCG), a substance found in green tea, can help fight various types of coronaviruses, including variants of SARS-CoV-2, the virus responsible for COVID-19. Notably, therefore, EGCG has long been a key component of the cutting-edge micronutrient program designed by scientists at the Dr. Rath Research Institute.
Green tea polyphenols have potent antioxidant and anti-inflammatory properties which contribute to their anticancer effects, cardiovascular benefits, and support of overall health. In addition to COVID-19, other conditions for which green tea and its extracts may be helpful include rheumatoid arthritis, Parkinson’s disease, and Alzheimer’s disease.
Recent research conducted at the Dr. Rath Research Institute has revealed amazing benefits of black tea that could prove to be game-changing in the battle against bacterial infections. These findings are especially significant given the growing threat of antibiotic resistance, a problem that limits the options for fighting difficult-to-treat infections such as methicillin-resistant Staphylococcus aureus (MRSA). Published in the prestigious journal PLOS ONE, the research utilizes a specific component of black tea known as theaflavin 3,3′-digallate (TF3).
To read how the United States Patent and Trademark Office has awarded the Dr. Rath Research Institute a patent on a game-changing micronutrient formula that can simultaneously inhibit multiple cellular mechanisms of infectivity caused by coronavirus, its variants, and mutants, see this article on our website.
Dr. Rath Health Foundation
Related posts
Research Suggests Probiotics Plus Vitamin D Supplements May Benefit People With Schizophrenia
Read more